RenovoRx, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 3.26 million compared to USD 3 million a year ago. Basic loss per share from continuing operations was USD 0.36 compared to USD 0.33 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | +0.13% | -13.01% | -53.28% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.28% | 25.63M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.45% | 22.67B | |
-9.79% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- RNXT Stock
- News RenovoRx, Inc.
- RenovoRx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023